PPT-Updates in Diabetic Nephropathy

Rodica Pop Busui MD PhD Division of Metabolism Endocrinology and Diabetes Michigan Comprehensive Diabetes Center University of Michigan Diabetes is the dominant cause of ESRD in USA. Patel University. Efficacy of Urinary N-Acetyl β- D- Glucosaminidase in Detecting Renal Tubular Damage: A Early Consequence in Type 2 Diabetes Mellitus leading to Diabetic Nephropathy. Kiran. . Sierra Nevada Nephrology Consultants. Outline. Define the illness. Recent state of Affairs. Pathology. Risk factors. Medication. Treatments. Diabetic nephropathy is a clinical . syndrome. Persistent . Parviz. . Shabane. Ramu Anandakrishnan. Arichanah. . Pulenthiran. Harold Garner. CNDP1 is an excreted . dipeptidase. that exists as a monomer or . homodimer. Its two . substrates are H-carnosine (preferred) and . IN. TYPE I DIABETIC NEPHROPATHY. DR.NASIM MUSA. Type I –IDDM is characterized by. The abrupt onset of symptoms. Insulinopenia. Dependence on injected insulin for life. Proneness to . ketoacidosis. .. kidney disease . in . diabetes :. In . either . type 1 or . type 2 diabetes : . 25 – 40. % . → diabetic . nephropathy in a 25 . y. Diabetes . → leading cause for ESRD. diabetic . nephropathy :. . nodushan. Fellow of endocrinology. Research institute for endocrine sciences. . . Shahid. . Beheshti. University of Medical Sciences.. Jul.2017. Agenda. Prevalence. Natural history . Objectives and background for this learning resource. Introduction:. This learning resource has been developed as part of a medical education initiative supported by Janssen. . The content of this slide kit has been developed by an advisory board of renal physicians, GPs and specialist nurses. The panel of experts . From ESH 2016 | LB 1:. Jean-Pierre . Fauvel. , MD. CHU Lyon, . Hôpital. E Herriot, Lyon, . France. Overview. Online risk prediction tool created to aid optimizing treatment of diabetic nephropathy. Egypt Rheumatol Rehab Vol. 30. No. 3, May, 2003 367Hemoglobin A is specifically eluted after washing away the HbA1fraction, and is quantified by direct photometric reading at 4/5 nm. The columns we ABSTRACTGreat advances have been made in the pathophysiologic and therapeutic areas of membranous nephropathy in the last years. The description of autoantibodies directed against phospholipase A2 rec 5 5 DOI: 10.7860/JCDR/2018/36574.12203 Original Article Miscellaneous Postgraduate Education Letter to Editor Short Communication Images in Medicine Experimental Research Clinician’s corner Revie P. Risk factors in the progression of dia-betic nephropathies. Ugeskr Laeger 2000; 162:P, NARVINGNatural course of kidney function in type 2 diabet-ic patients with diabetic nephropathy. Diabet Med199 P. Belton, M. Carmody, J. Doino:hue and W. F. O'Dwyer of Nephrology, Jervis Street Hospital, Dublin 1. I gA nephropathy is a newly described glomerulonephritis. It is a relatively common nephritis o . Shahin. . Nosratzehi. . volume . 14 | JUNE 2018 | . 361. Agenda. Introduction. Classical phenotype. Mechanisms of . DKD. Immediate effects of . hyperglycemia. Late effects of . hyperglycemia. Non-protein uric phenotype.